,i #aaeth ,,congress #b;d ,session ,h4 ,r4 #eeha ,,in ,,the ,,house ,,of ,,representatives ,april #bc1 #bjah ,mrs4 ,brooks of ,indiana 7for herself and ,mr4 ,schneider7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on the ,judiciary1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to require training for prescribers of controlled substances1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,abuse ,deterrent and ,prescriber ,training ,act of #bjah or the ,,adapt ,act of #bjah4 #b4 ,practitioner education 7a7 ,in general ,part ,c of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hba et seq47 is amended-- 7#a7 in section #cjc 7#ba ,u4,s4,c4 #hbc71 by adding at the end the following3 7k7 7#a7 ,the ,attorney ,general shall not register1 or renew the registration of1 a practitioner under subsection 7f7 who is licensed under ,state law to prescribe controlled substances in schedule ,,ii1 ,,iii1 ,,iv1 or ,v1 unless the practitioner submits to the ,attorney ,general1 for each such registration or renewal request1 a written certification that the practitioner has completed #c hours of training under a training program meeting the criteria in paragraph 7#b7 during the period applicable under paragraph 7#e74 7#b7 ,a training program meets the criteria in this paragraph if the program-- 7,a7 includes information on-- 7i7 safe opioid prescribing guidelines1 including the ,guideline for ,prescribing ,opioids for ,chronic ,pain issued by the ,centers for ,disease ,control and ,prevention2 7ii7 the risks of opioid medications and other prescription drugs that are controlled substances2 7iii7 pain management1 including the need to provide individualized care particularly for active cancer treatment1 palliative care1 and end-of-life care2 7iv7 early detection of opioid and other substance use disorders2 7v7 the risks of prescribing opioids to any individual in recovery from a substance use disorder2 7vi7 a basic understanding of addiction2 7vii7 the treatment of opioid-dependent patients and their treatment options2 7viii7 the risks of misuse of all prescription drugs that are controlled substances2 and 7ix7 alternative non-opioid pain management medications and other effective treatments2 and 7,b7 is-- 7i7 approved by the ,state agency with primary responsibility for licensing the practitioner to prescribe controlled substances2 or 7ii7 if such ,state agency does not have in effect an approval of any training program for purposes of this subsection1 conforms to the model training program in effect under paragraph 7#d74 7#c7 ,notwithstanding paragraph 7#b71 a training program on prescribing opioids used by a ,state for purposes of licensing health care practitioners is deemed to meet the criteria in paragraph 7#b7 if the program has been in effect since before the date of enactment of the ,abuse ,deterrent and ,prescriber ,training ,act of #bjah4 7#d7 ,the ,secretary of ,health and ,human ,services shall-- 7,a7 by not later than #fj days after the date of enactment of the ,abuse ,deterrent and ,prescriber ,training ,act of #bjah1 develop a model training program on prescribing opioids to be used for purposes of paragraph 7#b77;,b77ii72 and 7,b7 by not later than #ij days after such date of enactment1 provide information about such model training program to the ,attorney ,general1 prescribers1 ,state licensing boards1 and continuing medical education providers4 7#e7 7,a7 ,in the case of a registration request1 and in the case of the first renewal request of a practitioner after the date of enactment of the ,abuse ,deterrent and ,prescriber ,training ,act of #bjah1 the training required by paragraph 7#a7 shall occur during the #a-year period preceding the registration or first renewal request4 7,b7 ,in the case of a renewal request that is not the first renewal request of a practitioner after such date of enactment1 the training required by paragraph 7#a7 shall occur during the #c-year period preceding the renewal request4 7#f7 ,the ,attorney ,general may-- 7,a7 take steps necessary to verify that a practitioner has completed a training program as required under paragraph 7#a71 including requiring a practitioner to provide information determined necessary by the ,attorney ,general2 and 7,b7 investigate a practitioner described in paragraph 7#a7 if the ,attorney ,general has reason to believe the practitioner filed an inaccurate or fraudulent written certification under paragraph 7#a74 7#g7 ,nothing in this subsection shall be construed to prevent a practitioner from using the same training both for purposes of satisfying the registration requirements of this subsection and for other purposes1 such as satisfying ,state licensing requirements4 2 and 7#b7 in section #cjd7;a7 7#ba ,u4,s4,c4 #hbd7;a771 by adding at the end the following3 ,a registration pursuant to section #cjc7;f7 issued to a practitioner who is required to comply with section #cjc7k7 may be denied or revoked by the ,attorney ,general upon a finding that the practitioner has failed to comply with section #cjc7k74 4 7b7 ,effective date ,the amendments made by subsection 7a7 shall take effect on the date that is #ahj days after the date of enactment of this ,act4 7c7 ,sunset ,effective on the date that is #e years after the date of enactment of this ,act1 the following provisions are repealed3 7#a7 ,subsection 7k7 of section #cjc of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc71 as added by subsection 7a77#a7 of this section4 7#b7 ,the sentence added by subsection 7a77#b7 of this section to the end of section #cjd7;a7 of such ,act 7#ba ,u4,s4,c4 #hbd7;a774 #c4 ,report to ,congress ,not later than #b years after the date of enactment of this ,act1 the ,comptroller ,general of the ,united ,states shall submit a report to ,congress on the effects of this ,act and the amendments made by this ,act1 including an analysis of-- 7#a7 whether there has been a reduction in the volume of opioids prescribed2 7#b7 whether there has been an increase in the likelihood that opioid-dependent patients receive substance use disorder treatment2 7#c7 whether there has been a reduction in opioid-related overdoses and deaths2 7#d7 whether training required by this ,act and the amendments made by this ,act has changed prescribing practices and increased patient referrals to treatment2 and 7#e7 the extent to which prescribers have conformed their practices to those recommended in training pursuant to this ,act and the amendments made by this ,act4